Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Noninvasive Neuromodulation Of The Subjective Value Network In Chronic Pain

NCT: NCT07798908 · NOT_YET_RECRUITING

NCT IDNCT07798908
StatusNOT_YET_RECRUITING
Start Date2026-12-01
Completion2030-12-01
SponsorNational Institute of Neurological Disorders and Stroke (NINDS) (NIH)
First posted
Last updated

Brief Summary

Study Description: This is an outpatient pilot study of the feasibility and tolerability of transcranial magnetic stimulation, directed to the network of brain regions responsible for assigning value to events, in patients with chronic pain. The primary hypothesis is that this study intervention will be feasible and tolerated well. The secondary hypothesis is that such study intervention will reduce the severity of chronic pain. Objectives: Primary Objective: To establish the feasibility and tolerability of multi-day TMS in chronic pain patients. Secondary Objective: To obtain preliminary information on whether network-targeted TMS changes chronic pain ratings. Exploratory Objectives: To evaluate effects of study intervention on moment-to-moment pain and emotional experience, continuous actigraphy, HEAL Core Common Data Elements, and, when fMRI is feasible, resting state functional connectivity before and after study intervention blocks. Endpoints: Primary Endpoint: Completion of at least two consecutive study intervention blocks, including one real on-target stimulation block and one off-target control stimulation block. Secondary Endpoint: Mean change in self-rated pain on the McGill Pain Questionnaire-Short Form after real on-target study intervention blocks compared with off-target control blocks. Exploratory Endpoints: Mean changes in Ecological Momentary Assessment, actigraphy, HEAL Core Common Data Elements, and, when fMRI is feasible, resting state functional connectivity after real on-target stimulation blocks compared with off-target control blocks.

Frequently Asked Questions

What is Noninvasive Neuromodulation Of The Subjective Value Network In Chronic Pain?

Noninvasive Neuromodulation Of The Subjective Value Network In Chronic Pain is a clinical trial registered under NCT07798908. Current status: NOT_YET_RECRUITING.

What is the status of NCT07798908?

The current status of NCT07798908 (Noninvasive Neuromodulation Of The Subjective Value Network In Chronic Pain) is: NOT_YET_RECRUITING.

When did Noninvasive Neuromodulation Of The Subjective Value Network In Chronic Pain start?

Noninvasive Neuromodulation Of The Subjective Value Network In Chronic Pain started on 2026-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.